您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:麦迪卫康2024 年报 - 发现报告

麦迪卫康2024 年报

2025-04-25港股财报心***
AI智能总结
查看更多
麦迪卫康2024 年报

24567183844727980828385 717 8121218 David Zheng Wang Campbells Corporate Services LimitedFloor 4, Willow House, Cricket SquareGrand Cayman KY1-9010Cayman Islands David Zheng Wang 183171712–1716 David Zheng Wang 2025326David Zheng Wang2025326 191001-1010 Floor 4, Willow HouseCricket SquareGrand Cayman KY1-9010Cayman Islands 97943 12 2159 www.mediwelcome.com 20242024 2024AIweb 3.0 2025326 2024 AIGCweb 3.0 AIweb 3.02024AIGCAI 20246web 3.0 AIweb 3.0APP 20241231747,87366,64527,63121,04932,49414,038,0241,306,769 20242024123153,926202312316.6%320,2962023123115.2% 2025 1. 2025 AIGC (CDSS) 2. 3. AIweb 3.0 2025 2024 AIGCAIGC—AIGC+AIGCweb 3.0 (i)(ii)(iii)(iv)CRO 20231231331.32.9%321.6 +App 20231231163.73.1%158.7 20231231136.80.2%137.1 2023123110.54.1%10.1 202312315.626.7%7.1(i)(ii) CRO CRO CRO2023123111.753.9%5.4 —202312313.04.9%3.2 20231231301.410.2%270.6(i)(ii) 2023123129.921.151.0202312319.0%15.9% 202312317.347.8%3.8(i)2.1(ii)1.7(iii)1.8(iv)1.1 2023123122.37.5%20.7(i)(ii) 2023123151.021.7%39.9 2023123132.742.8%18.7 (i)AI(ii) 11.72023123120.411.7 202312311.316.6%1.1(i)20231231(ii)20231231 1.8202312310.3 46.92023123196.1(i)(ii)(iii)20231231 0.32023123115.92023123115.0 2023123156.92024123150.4(i)(ii) 2023123132.3202412 3137.6 20241231202312310.5202312312.278.9% 2024123143.82023123188.8 (i)(ii) 2024123171.72023123180.410.8% 202412318.7202312319.6 202412 3139.02023123121.512 202412316.5202312313.5 2024123153.3%2023123117.9% 2024123112.7202312311.6(i)(ii) 2021119 20241231200,000,000 2024123120231231 2024123120231231 202412313112023123133566.92023123196.430.7% 201991820201221—— D.— 2.—— D.— 3. 201851720185175,150,0009% 2018 2024123119.41%2023123119.41%2024123115.12023123114.220241231194.120231231214.37.8%202312316.6% 0.8202312312.320231231 (i)(ii)(iii) 20241231 20241231 C1 20241231 David Zheng Wang 3843 20241231 20241231 3.13 DavidZheng Wang 20241231DavidZheng WangC.1.4 20249273.09D 20241231 A/BA/BA/B2024930A/B2024930A/B2024312A/B A/BZhang Yitao2024312A/B A/BDavid Zheng WangA/BA/BFei John Xiang2024312A/B 2 David Zheng Wang A.2.1 20241231202312312024630 2/22/2David Zheng Wang(2024312)2/2Fei John Xiang(2024312)0/0 David Zheng WangDavidZheng Wang 17 David Zheng Wang(2024312)1/11/1Fei John Xiang(2024312)0/0 1500,0007500,0011,000,00041,000,0011,500,000–1,500,0012,000,000– David ZhengWangDavid Zheng Wang 20253261/1David Zheng Wang20253261/120243121/1Fei John Xiang20243120/020253260/0 17 17 41-5051-6061-70 512 12.5%(i)(ii)(iii)(iv) 112100110103 1. 2.3.13 3. 4. 5. • • • • • • • • • • • • (a) (b)(c)(d)(e) (f) (g) D.3.3 20241231C3 201991820211025 3843 202412313.29 20241231 Committee of Sponsoring Organizations of the Treadway Commission (COSO)Internal Control —Integrated Framework (2013) ••• •• 2024 20241231 20241231 20241231 7278 20241231 12.3 21 15 183171712-1716(852) 2862 8555(852) 2865 0990(852) 2529 6087 8121218compsec@mediwelcome.com (86)10-56831999 http://www.mediwelcome.com (www.hkex.com.hk)http://www.mediwelcome.com 8121218compsec@mediwelcome.com 20241231 4920192212019918 2001520164 19957 582019918 200092016380% 19927 492019918 2006451% 19967 452024930200312 19977201012202111 442019918 20037200682012620136201372017720177201712202072021720217 20181 2003720091 6220201221 201730218620199269620191119209620201221116720188688321 2017320213300294.SZ2015820218002826.SZ2015620216300158.SZ2009720141300181.SZ200811201411600998.SH 19857200411201812 David Zheng Wang6220201221 19951020199WangOSF Healthcare2005120199WangUniversity of Illinois College of Medicine at PeoriaUICOMP20112017Wang201910WangUICOMP Wang19896(Michigan State University)Wang(American Academy of Neurology) 4920201221 1997920055Hill Taylor LLCAcergy S.A.ACGY2007320074002624PWRD 1997720037 48200911 19983199912009112016320164 19987 4020115 20091201152262 20057 482019918 4020211025108 20241231 (i)(ii)(iii)2019CRO33 7175457 2024123120241231 202412 31 7219020241231182024123128%74% 921902024123121202412311%100% 33 20241231 4 2024123182 202412312023 20241231 2025625 2025619 2025625 183171712–1716 2024123112 2620241231 20241231 20241231 70% 200112112008910201626202232950% 202247202251 • •• ••• 20241231 1. 201975(i)(ii)(iii)(iv)(v)(vi)(vii)(viii)(ix) 2. 201975 3. 201975 4. 201975(i)(ii)(iii) 20241231(i)(ii) (i) (ii) (iii) (iv) (v) (vi) 202412312023 (a)(b)(c)(a)(b) 2024123132.22%20.14%20.14%9.13%Zhang Yitao14AZhang YitaoA 14A.105(i)14A(ii)(iii)303305 14A.5520241231(i)(ii)(iii) (i)20241231(ii)(iii)20241231 14A.56202412313000740 2024123130 3014A 2024123114A 202493020249302024312 Zhang Yitao2024312 Fei John Xiang2024312David Zheng Wang 59|2024 2025625 20241231 20241231 20241231 20241231XV352 20241231200,000,000 (2)Zhang Yitao20191013— (3)108,519,00040,651,0002,600,00065,268,000(2) (4)108,519,00025,415,00083,104,000(2) 20241231X